American Medical Association Home Page
AMA Web CME Main Page
Privacy Policy
CME Info   Site Map References    
American Medical Association Home Page
CME Introduction
Ethics
Case Introduction
Non-Directive Counseling
Testing Process
Test Results

References

 
01 of 03

American Society of Clinical Oncology (ASCO) Cancer Genetics and Cancer Predisposition Testing Curriculum

Biesecker BB, et al. Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am J Med Genet. 2000;93:257-263. PubMed abstract

Burke W, Daly M, Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2 Cancer Genetics Studies Consortium. JAMA. 1997;277:997-1003. (JAMA published earlier than 1998 not available online). PubMed abstract

The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child and Human Development. The reduction in risk of ovarian cancer associated with oral contraceptive use. N Engl J Med. 1987;316(11):650-655. PubMed abstract

Constantino JP, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999 Sep 15;91(18):1541-8. PubMed abstract

Di Prospero LS, et al. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. CMAJ. 2001;164:1005-1009. PubMed abstract

Dorval M, et al. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. J Clin Oncol 2000;18:2135-2142. PubMed abstract

Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trial. Lancet. 1998;351(9114);1451-1467. PubMed abstract

Easton DF et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet. 1995;56:265-271. PubMed abstract

Feuer EJ et al (1993): The lifetime risk of developing breast cancer. JNCI 85: 892-897. PubMed abstract

Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90(18):1371-1388. PubMed abstract

 

Back
|
Next
American Medical Association Home Page
Top of Page